Human Cytomegalovirus Infection of Human Hematopoietic Progenitor Cells

References

• Stagno S, Reynolds D W, Huang E S, Thames S D, Smith R J, Alford C A. Congenital cytomegalovirus infection. N. Engl. J. Med. 302 1977; 1254–1258
   PubMed Web of Science ®Google Scholar
• Bevan W M, Daw R A, Day J PR, Ala F A, Walker M R. Polymerase chain reaction for detection of human cytomegalovirus infection in blood donor population. Br. J. Hematol. 78 1991; 94–99
   PubMed Web of Science ®Google Scholar
• Larsson S, Soderberg-Naucler C, Wang F Z, Moller E. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 1998; 12 Suppl(7)S701–S710
   Google Scholar
• Mutter W, Reddehase M J, Busch P W, Buhring H J, Koszinowski U H. Failure in generating hematopoietic stem cells is the primary cause death from cytomegalovirus disease in theimmunocomprimised host. J. Exp. Med. 167 1988; 1645–1658
   PubMed Web of Science ®Google Scholar
• Chou S W. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. J. Infect. Dis. 160 1989; 11–15
   PubMed Web of Science ®Google Scholar
• Brandwine J M, Callum J, Sutcliffe S B, Scott S B, Keating A. Analysis of factor affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. Bone marrow transplantation 6 1990; 291–294
   Google Scholar
• Weller T H. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II. N. Engl. J. Med. 285 1971; 267–274
   PubMed Web of Science ®Google Scholar
• Winston D J, Ho W G, Lin CH Budinger, MD, Champlin R E, Gale R P. Delay in platelet recovery after bone marrow transplantation: Impact of cytomegalovirus infection. Am. J. Med. 106 1984; 128–135
   PubMed Web of Science ®Google Scholar
• Verdonck L F, de Gast G C, van Heugten H G, Nieuwenhuis H K, Dekker A W. Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood 1991; 78: 844–848
   PubMed Web of Science ®Google Scholar
• Rowley S D, Plantadosi S, Marcellus D C, Jones R J, Davidson N E, Davis J M, Kennedy J, Wiley J M, Wingard J R, Yeager A M. Bone marrow transplantation 1991; 7: 183–191
   PubMed Web of Science ®Google Scholar
• Choi J H, Kim D W, Cho S G, Jeong D C, Han C W, Shin W S, Min W S, Kim H K, Kim C C, Kim D J. Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogenic bone marrow transplantation. Bone marrow Transplant. 19 1997; 187–190
   PubMed Web of Science ®Google Scholar
• Baldanti F, Underwood M R, Talarico C L, Simoncini L, Sarasini A, Biron K K, Gerna G. The Cys607--> Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients. Antimicrob Agents Chemother 42 1998; 444–446
   Google Scholar
• Ippoliti C, Morgan A, Warkentin D, van Besien K, Mehra R, Khouri I, Giralt S, Gajewski J, Champlin R, Andersson B, Przepiorka D. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovirus. Bone Marrow Transplant 1997; 20: 491–495
   PubMed Web of Science ®Google Scholar
• Chesney P J, Taher A, Gilbert E MF, Shahidi N Y. Intracellular inclusions in megakaryocytes in congenital cytomegalovirus infection. J. Pediatr. 92 1979; 957–963
   Google Scholar
• Foster K M, Jack I. A prospective study of the role of the cytomegalovirus in post-transfusion mononucleosis. N. Engl. J. Med. 280 1969; 1311–1319
   PubMed Web of Science ®Google Scholar
• Risdall R J, McKenna R W, Nesbit M E, Krivit W, Balfour H H, Simmons R L, Brunning R D. Cancer 1979; 44: 993–999
   PubMed Web of Science ®Google Scholar
• Simmons P, Kaushansky K, Torok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc. Natl. Acad. Sci. USA 1990; 1386–1390
   PubMed Web of Science ®Google Scholar
• Maciejewski J, Bruening E, Young N S, St Jeor S. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1991; 80: 170–178
   Web of Science ®Google Scholar
• Zhuravskaya T, Maciejewski J P, Netski D M, Mackintosh R F, St Jeor S. Persistence of human cytomegalovirus in bone marrow cultures. Implication for viral latency, spread and reactivation. Blood 1997; 90: 2482–2491
   PubMedGoogle Scholar
• Singh G K, Ruscetti F W. Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 1990; 75: 1965–1973
   PubMed Web of Science ®Google Scholar
• Movassagh M, Gozlan J, Senechal B, Baillou C, Petit J C, Lemoine F M. Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood 1996; 88: 1277–1283
   Google Scholar
• Rakusan T A, Juneja H S, Fleichman W R. Inhibition of hematopoietic colony formation by human cytomegalovirus. J. Infect. Dis. 159 1989; 127–130
   PubMed Web of Science ®Google Scholar
• Gibbons A E, Price P, Shellam G R. Analysis of hematopoietic stem cell and progenitor cell population in cytomegalovirus-infected mice. Blood 1995; 86: 473–481
   PubMed Web of Science ®Google Scholar
• Apperley J F, Dowding C, Hibbin J, Buiter J, Matutes E, Sissons P J, Gordon M, Goldman J M. The effect of cytomegalovirus on hematopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp. Hematol. 17 1989; 38–45
   Google Scholar
• Meyer-Konig U, Hufert F T, von Laer D M. Infection of blood and bone marrow cells with the human cytomegalovirus in vivo. Leuk Lymphoma 1997; 25: 445–454
   PubMed Web of Science ®Google Scholar
• Soderberg-Naucler C, Fish K M, Nelson J A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91 1997; 119–126
   PubMed Web of Science ®Google Scholar
• Danker W M, McCutchan J A, Richman D D, Hirata K, Spector S A. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J. Infec. Dis. 161 1990; 31–36
   PubMed Web of Science ®Google Scholar
• Preiksaitis J K, Janowska-Wieczorek A. Persistence of cytomegalovirus in human long-term bone marrow culture: relationship to hematopoiesis. J. Med. Virol. 35 1991; 76–84
   PubMed Web of Science ®Google Scholar
• Lagneaux L, Delforge A, Snoeck R, Bosnians E, Moreau J F, Taupin J L, De Clercq E, Stryckmans P, Bron D. Human cytomegalovirus increases constitutive production of Interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells. Blood 1996; 87: 56–66
   Google Scholar
• Taichman R S, Nassiri M R, Reilly M J, Ptak R G, Emerson S G, Drach J C. Infection and replication of human cytomegalovirus in bone marrow stromal cells: effects on the production of IL-6, MIP-1 alpha, and TGF-betal. Bone marrow Transplant 19 1997; 471–480
   PubMed Web of Science ®Google Scholar
• Boeckh M, Hoy C, Torok-Storb B. Occult cytomegalovirus infection of marrow stroma. Clin. Infect. Dis. 26 1998; 209–210
   PubMed Web of Science ®Google Scholar
• Admirand J H, Bruening E E, Maciejewski J P, St Jeor S. Mechanisms of induction of Interleukin-6 by human cytomegalovirus. Arch Virology (submitted) 1997
   Google Scholar
• Almeida G D, Porada C D, St Jeor S, Ascensao J L. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 1994; 83: 370–376
   PubMed Web of Science ®Google Scholar
• Mayer A, Podlech J, Kurz S, Steffens H P, Mailberger S, Thalmeier K, Angele P, Dreher L, Reddehase M J. Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hematopoietin genes J. Virol. 71 1997; 4589–4598
   Google Scholar
• Reddehase M J, Dreher-Stumpp L, Angele P, Balthesen M, Susa M. Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma. Ann Hematol. 1992; 64(Suppl: A125–127)
   PubMedGoogle Scholar
• Mackintosh F R, Adlish J, Hall S W, St Jeor S, Smith E, Tavassoli M, Zanjani E D. Exp Hematol. 1993; 2: 243–250
   Google Scholar
• Duncombe A S, Grundy J E, Prentice H G, Brenner M K. IL-2 activated killer cells may contribute to cytomegalovirus induced marrow hypoplasia after bone marrow transplantation. Bone Marrow transplantation 1991; 7: 81–87
   PubMed Web of Science ®Google Scholar
• Mori T, Ando K, Tanaka K, Ikeda Y, Koga Y. Fas-mediated apoptosis of the hematopoietic progenitor cells in mice infected with murine cytomegalovirus. Blood 89 1997; 3565–3573
   Google Scholar
• Selleri S, Anderson S, Young N S, Maciejewski J. IFN-γ and TNF-α mediates hematopoietic suppression in vitro through apoptosis of hematopoietic progenitors. J. Cellular Physiology 156 1995; 538–546
   PubMed Web of Science ®Google Scholar
• Maciejewski J, Selleri C, Anderson S, Young N S. Fas antigen expression on hematopoietic progenitor cells and enhancement of interferon-gamma and tumor necrosis factor-alpha mediated inhibition of hematopoiesis. Blood. 85 1995; 3183–3190
   Google Scholar
• Toro A I, Ossa J. PCR activity of CMV in healthy CMV-seropositive individuals: does latency need redefinition. Res. Virol. 147 1996; 233–238
   PubMedGoogle Scholar
• Brytting M, Mousavi-Jazi M, Bostrom L, Larsson M, Lunderberg J, Ljungman P, Ringden O, Sundqvist V A. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients. Tranplantation 60 1995; 961–965
   Google Scholar
• Hersman J, Meyers J D, Thomas E D, Buckner C D, Clift I. The effects of granulocyte transfusions on the incidence of cytomegalovirus infection after allogenic bone marrow transplantation. Ann. Intern. Med. 96 1982; 142–149
   Google Scholar
• Lang D J, Ebert P A, Rodgers B M, Boggess H P, Rixse R S. Reduction of post-trasfusion cytomegalovirus infection following the use of leukocyte depleted blood. Transfusion 17 1977; 391–398
   PubMed Web of Science ®Google Scholar
• De Graan-Henzen Y CE, Gratama J W, Mudde G C, Verdonck L F, Houbiers J GA, Brand A, Sebens F W, Van Loon A M, The T H, Willemze R, De Gast G C. Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 29 1989; 757–762
   PubMed Web of Science ®Google Scholar
• Honda J, Okubo Y, Imamura Y, Kusaba M, Saruwatari N, Oizumi K. Flowcytometric detection of cytomegalovirus antigen in peripheral blood cells after bone marrow transplantation. Br. J. Hematol. 99 1997; 414–417
   Google Scholar
• Link H, Battmer K, Stumme C. Cytomegalovirus infection in leucocytes after bone marrow transplantation demonstrated by mRNA in situ hybridization. Br. J. Hematol. 85 1993; 573–577
   Google Scholar
• Fietze E, Prosch S, Reinke P, Stein J, Docke W D, Staffa G, Loning S, Devaux S, Emmrich F, von Baehr R. Cytomegalovirus infection in transplant recipients. The role of tumor n ecrosis factor. Transplantation 58 1994; 675–680
   Google Scholar
• Larsson S, Sodeberg-Naucler C, Moller E. Productive cytomegalovirus (CMV) infection in CD13-positive peripheral blood mononuclear cells from CMV infected individuals: Implications for prevention of CMV transmission. Transplantation 65 1998; 411–415
   PubMed Web of Science ®Google Scholar
• Saltzman R L, Quirk MR, Jordan M C. Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J. Clin. Invest. 81 1988; 75–81
   Google Scholar
• Taylor-Wiedeman J, Sissons J GP, Borysiewicz L K, Sinclair J H. Monocytes are major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. J. Gen. Virol. 72 1991; 2059–2064
   Google Scholar
• Taylor-Wiedeman J A, Hayhurst G P, Sissons J GP, Sinclair J H. Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J. Gen. Virol. 74 1993; 265–273
   PubMed Web of Science ®Google Scholar
• Fajac A, Vidaud M, Lebargy F, Stephan F, Ricci S, Geslin P, Goossens M, Bernaudin J F. Evaluation of human cytomegalovirus latency in alveolar macrophages. Am. J. Respir. Crit. Care Med. 149 1994; 495–499
   PubMed Web of Science ®Google Scholar
• Hackstein H, Boucher K, Merz H, Kirschner H, Bein G. Bllod leukocytes are not primary latent site of cytomegalovirus. Beitr. Infusionsther. Transfusionsmed 1996; 33: 235–240
   PubMedGoogle Scholar
• Hendrix R M, Wagenaar M, Slobbe R L, Bruggeman C A. Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J. Clin. Pathol. 50 1997; 59–63
   PubMed Web of Science ®Google Scholar
• Guetta E, Guetta V, Shibutani T, Epstein S E. Monocytes harboring cytomegalovirus: interaction with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury. Cir. Res. 81 1977; 8–16
   Google Scholar
• Waldman W J, Knight D A, Huang E H, Sedmak. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J. Infect. Dis. 171 1995; 263–272
   Google Scholar
• Sodeberg C, Larsson S, Bergstedt-Lindqvist S, Moller E. Identification of blood mononuclear cells permissive of cytomegalovirus infection in vitro. Transplant. Proc. 25 1993; 1416–1418
   Google Scholar
• Dugging L R, Garnett H M. Interaction of strain AD169 and clinical isolate of cytomegalovirus with peripheral monocytes: the effect of lipopolysaccaride stimulation. J. Infect. Dis. 155 1987; 891–896
   Google Scholar
• Einhom L, Ost A. Cytomegalovirus infection of human blood cells. Cytomegalovirus infection of human blood cells. J. Infect. Dis. 149 1984; 207–214
   Google Scholar
• Maciejewski J, Bruening E, Donahue R, Young N S, St Jeor S. Human cytomegalovirus infection of mononucleated phagocytes. Virology 1993; 195: 327–336
   PubMed Web of Science ®Google Scholar
• Ibanez C E, Schrier P, Ghazal P, Wiley C A, Nelson J A. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65 1991; 6581–6587
   Google Scholar
• Rice G PA, Schrier R D, Oldstone M BA. Cytomegalovirus infects human lymphocytesand monocytes: Virus expression is limraited to immediate-early gene products. Proc. Natl. Acad. Sci. USA 81 1984; 6134–6139
   Google Scholar
• Hayashi K, Saze K, Uchida Y. Studies of latent cytomegalovirus infections: the macrophage as a virus-harboring cell. Microbiol. Immunol. 29 1985; 1–15
   Google Scholar
• Smith P D, Saini S S, Reffeld M, Manischewitz J F, Wahl S M. Cytomegalovirus inductionof tumor necrosis factor-alpha by human cytomegalovirus and mucosal macrophages. J. Clin. Invest. 90 1992; 1642–1648
   PubMed Web of Science ®Google Scholar
• Kondo K, Mocarski E S. Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis Suppl 1995; 99: 63–67
   PubMedGoogle Scholar
• Kondo K, Kaneshima H, Mocarski E S. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91 1994; 11879–11883
   PubMed Web of Science ®Google Scholar
• Andreu G, Belhocine R, Klaren J, Fretz C, Lejus C. Why remove leukocytes from labile blood products in 1995? Transfus. Clin. Biol. 3 1996; 57–74
   PubMed Web of Science ®Google Scholar
• Couriel D, Canosa J, Engler H, Collins A, Dunbar C, Barrett A J. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplant 18 1996; 347–353
   Google Scholar
• Staak K, Prosch S, Stein J, Priemer C, Ewert R, Docke W D, Kruger D H, Volk H D, Reinke P. Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro. Blood May 15, 1997; 89((10))3682–90
   PubMed Web of Science ®Google Scholar
• Haagmans B L, Stals F S, van der Meide P H, Bruggeman C A, Horzinek M C, Schijns V E. Tumor necrosis factor alpha promotes replication and pathogenecity of rat cytomegalovirus. J. Virol. 1994; 68: 2297–2304
   PubMed Web of Science ®Google Scholar
• Chaudauhuli A C, St Jeor S, Maciejewski J P. The role of Fas in the depletion of human cytomegalovirus infected cells and control of virus spread. J. Gen. Virol. 1997, (submitted)
   Google Scholar
• Hahn G, Jores R, Mocarski E S. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 1998; 95: 3937–42
   PubMed Web of Science ®Google Scholar